Literature DB >> 29174980

PDGF-mediated PI3K/AKT/β-catenin signaling regulates gap junctions in corpus cavernosum smooth muscle cells.

Xiang Zhang1, Fan Zhao1, Jian-Feng Zhao2, Hui-Ying Fu3, Xiao-Jun Huang2, Bo-Dong Lv4.   

Abstract

Erectile dysfunction (ED) is the most common sexual disorder that men report to healthcare providers. Gap junctions (GJs) are thought to be responsible for synchronous shrinkage of corpus cavernosum smooth muscle cells (CCSMCs), and play thus an important role in the maintenance of an erection. Hypoxia has been suggested as a pathological mechanism underlying ED. Here we demonstrate that hypoxia increased the expression of platelet-derived growth factor (PDGF) and the main GJ component connexin (Cx)43 in CCSMCs. Inhibiting PDGF receptor (PDGFR) activity decreased Cx43 expression. Treatment with different concentrations of PDGF increased the levels of phosphorylated protein kinase B (AKT), β-catenin, and Cx43, whereas inhibition of PDGFR or activation of phosphatidylinositol 3 kinase (PI3K)/AKT signaling altered β-catenin and Cx43 expression. Meanwhile, silencing β-catenin resulted in the downregulation of Cx43. These results demonstrate that PDGF secretion by CCSMCs and vascular endothelial cells is enhanced under hypoxic conditions, leading to increased Cx43 expression through PI3K/AKT/β-catenin signaling and ultimately affecting GJ function in ED. Thus, targeting this pathway is a potential therapeutic strategy for the treatment of ED.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKT; Connexin 43; Erectile dysfunction; PI3K; Platelet-derived growth factor; β-catenin

Mesh:

Substances:

Year:  2017        PMID: 29174980     DOI: 10.1016/j.yexcr.2017.11.025

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Effect of HongJing I in Treating Erectile Function and Regulating RhoA Pathway in a Rat Model of Bilateral Cavernous Nerve Injury.

Authors:  Miao-Yong Ye; Fan Zhao; Ke Ma; Kang Zhou; Wen-Jie Huang; Yin-Feng Ma; Jian-Feng Zhao; Hui-Ying Fu; Zeng-Bao Xu; Bo-Dong Lv
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-16       Impact factor: 2.629

2.  Simvastatin preparations promote PDGF-BB secretion to repair LPS-induced endothelial injury through the PDGFRβ/PI3K/Akt/IQGAP1 signalling pathway.

Authors:  Xia Zheng; Wang Zhang; Zhen Wang
Journal:  J Cell Mol Med       Date:  2019-10-01       Impact factor: 5.310

3.  Proteomic analysis of oxidative stress response in human umbilical vein endothelial cells (HUVECs): role of heme oxygenase 1 (HMOX1) in hypoxanthine-induced oxidative stress in HUVECs.

Authors:  Pei Zhu; Tao Qi; Zhan-Sen Huang; Hao Li; Bo Wang; Jia-Xin Feng; Shuai Ma; Heng-Jun Xiao; Yu-Xin Tang; Wei Liu; Jun Chen
Journal:  Transl Androl Urol       Date:  2020-04

4.  Whole-transcriptome analysis of rat cavernosum and identification of circRNA-miRNA-mRNA networks to investigate nerve injury erectile dysfunction pathogenesis.

Authors:  Jie Huang; Jianxiong Ma; Jie Wang; Ke Ma; Kang Zhou; Wenjie Huang; Fan Zhao; Bodong Lv; Qing Hu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  The promoting effects of activated olfactory ensheathing cells on angiogenesis after spinal cord injury through the PI3K/Akt pathway.

Authors:  Xiaohui Wang; Chao Jiang; Yongyuan Zhang; Zhe Chen; Hong Fan; Yuyang Zhang; Zhiyuan Wang; Fang Tian; Jing Li; Hao Yang; Dingjun Hao
Journal:  Cell Biosci       Date:  2022-03-04       Impact factor: 7.133

Review 6.  Gap junction-mediated cell-to-cell communication in oral development and oral diseases: a concise review of research progress.

Authors:  Wenjing Liu; Yujia Cui; Jieya Wei; Jianxun Sun; Liwei Zheng; Jing Xie
Journal:  Int J Oral Sci       Date:  2020-06-12       Impact factor: 6.344

7.  Effect of berbamine on invasion and metastasis of human liver cancer SMMC-7721 cells and its possible mechanism.

Authors:  Bin-Bin Yu; Li-Li Liu; Jia-Dong Yan; Jian-Bo Cao; Ying Cao
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.